FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69273
News■ Unclear/unknown
Active Pharmaceutical Ingredients (API) Market worth $199.42 billion by 2031
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 14:30 UTC
LAST UPDATE2026-10-07 14:30 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
API market growth forecast implies rising input demand for pharma manufacturers, but no ticker is named.
Sector forecast, no specific equity catalyst
CATALYST TO WATCH
API pricing or capacity announcements
MAIN RISK
Vendor forecast methodology unverified
FULL DISPATCH
DELRAY BEACH, Fla., Oct. 7, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Active Pharmaceutical Ingredients (API) Market is projected to reach USD 199.42 billion by 2031 from USD 149.02 billion in 2026, at a CAGR of 6.0% during the forecast period. Browse 747 market data...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Schizophrenia Market to Gain Momentum During the Forecast Period (2026-2036), with Growing Pipeline of Novel and Long-Acting Therapies2026-10-07 14:31 UTC
Schizophrenia Market to Gain Momentum During the Forecast Period (2026-2036), with Growing Pipeline of Novel and Long-Acting Therapies2026-10-07 14:31 UTC
→CORRELATIONshares Healthcare
tgin Foundation's 9th Annual Cocktails for the Cure Gala Returns to Advance Breast Health Equity and Expand Access to Care2026-10-07 15:00 UTC
tgin Foundation's 9th Annual Cocktails for the Cure Gala Returns to Advance Breast Health Equity and Expand Access to Care2026-10-07 15:00 UTC
→CORRELATIONshares Healthcare
Omega Healthcare Is Recognized Across Three Categories in Avtar & Seramount's 2026 Best Companies Rankings2026-10-07 15:00 UTC
Omega Healthcare Is Recognized Across Three Categories in Avtar & Seramount's 2026 Best Companies Rankings2026-10-07 15:00 UTC
→CORRELATIONshares Healthcare
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)2026-10-07 15:15 UTC
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)2026-10-07 15:15 UTC
→CORRELATIONshares Healthcare
GovCIO Partners with CLEAR to Pilot a New Way for Veterans to Securely Access VA.gov2026-10-07 15:26 UTC
GovCIO Partners with CLEAR to Pilot a New Way for Veterans to Securely Access VA.gov2026-10-07 15:26 UTC
→CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.